Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Jan 31, 2012 terifay robert j Officer Automatic Sell 13,689 90.07
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Jan 19, 2012 goldberg murray a Officer Automatic Sell 23,617 79.53
Jan 12, 2012 ryan arthur f Director Sell 25,500 78.86 - 79.09
Sep 21, 2011 brown michael s Director Automatic Sell 5,000 78.00
Jan 20, 2012 goldberg murray a Officer Automatic Sell 17,183 77.86 - 79.51
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Jan 11, 2012 terifay robert j Officer Automatic Sell 9,019 74.20
Sep 8, 2011 brown michael s Director Automatic Sell 5,000 74.00
Jan 11, 2012 roberts william Officer Automatic Sell 22,148 73.99 - 77.05
Jan 10, 2012 roberts william Officer Automatic Sell 37,852 73.92 - 74.35
Jan 10, 2012 terifay robert j Officer Automatic Sell 10,981 73.92
Sep 8, 2011 goldberg murray a Officer Automatic Sell 14,258 72.60
Sep 7, 2011 brown michael s Director Automatic Sell 5,000 69.00
Sep 7, 2011 goldberg murray a Officer Automatic Sell 13,531 67.50 - 70.41
Sep 7, 2011 roberts william Officer Automatic Sell 6,503 67.48 - 70.38
Sep 7, 2011 stahl neil Officer Automatic Sell 33,760 67.47 - 70.40
Sep 7, 2011 aberman michael s Officer Automatic Sell 3,377 67.39 - 70.39
Sep 9, 2011 goldberg murray a Officer Automatic Sell 7,542 67.19 - 69.08
Sep 21, 2011 goldberg murray a Officer Automatic Sell 4,200 67.00
Showing 301-320 of 897 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)